A new treatment option for older, sicker patients with sickle cell disease is on the way Half of patients in a trial have safely stopped immunosuppressant medication following a modified blood stem-cell transplant for severe sickle cell disease, according to a study in the July 1 issue of the emJournal of the American Medical Association/em. The trial was conducted at the National Institutes of Health's Clinical Center in Bethesda, Maryland, by researchers from ...
Read More
No comments:
Post a Comment